CIK 0001833214
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
SAB Biotherapeutics, Inc.
Sign in to watch- Ticker
- SABS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 853899721
- Phone
- +1 305-845-2813
- Business address
- 777 W 41ST ST, SUITE 401, MIAMI BEACH, FL, 33140
- Former names
- Big Cypress Acquisition Corp.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 1,740 shares at $0.88 ($1,531)
- 4 Open-market buy CHIEF FINANCIAL OFFICER bought 5,000 shares at $0.90 ($4,500)
- 4 Open-market buy Executive Chairman bought 11,000 shares at $0.89 ($9,842)
- 4 Option exercise Director acquired 4,584,571 shares (option exercise)
- 4 Option exercise Director acquired 4,584,571 shares (option exercise)
- 4 Option exercise Director acquired 2,857,142 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 8 · 151 filings